SAFETY ANALYSIS OF THE IMMUNOSUPPRESSANTS USE IN RENAL FAILURE PATIENTS

Fernanda Toaldo, Flavia Lorenzen dos Santos, Fernanda Cristina Ostrovski Sales, Jaqueline de Jesus Aschenbrenner

Abstract


Acute renal failure (ARF) and chronic renal failure (CRF) are pathologies with increasing incidence recently in Brazil. According to the Brazilian Society of Nephrology (2018), the number of patients with these comorbidities has increased by approximately 200% in 16 years, with organ transplantation as an alternative treatment. One of the main post-renal transplant therapies is the use of immunosuppressants to contain graft rejection. However, the safety of this pharmacotherapy is still discussed, due to the high probability of adverse reactions occurring. This study presented and analyzed numerical data regarding the occurrence of adverse drug reaction (ADR) related to immunosuppressants used as pharmacotherapy by patients with ARF or CRF hospitalized in a University Hospital of Curitiba county, PR. It is a retrospective observational study based on the analysis of physical and electronic records of the evolution of acute or chronic renal insufficiency patients through active search in immunosuppressive dispensing tables. This study included records of 162 patients, and 118 of them had one or more possible immunosuppressive reactions. We observed that the most prevalent ADR in the study was “opportunistic infection” and the lowest prevalence “hypoalbuminemia.” For better result reliability, Naranjo’s algorithm was applied, where “infection” remained relevant in 26% of its cases classified by the algorithm as “probable.” Given the results, the importance of the clinical pharmacist in the optimization of the immunosuppressive pharmacotherapy 
used by the renal insufficient patients of the hospital in question is observed.


Keywords


clinical pharmacy, immunosuppressants, adverse drug reactions



DOI: http://dx.doi.org/10.14450/2318-9312.v32.e4.a2020.pp374-382

Refbacks

  • There are currently no refbacks.


Copyright (c) 2020 Fernanda Toaldo, Flavia Lorenzen dos Santos, Fernanda Sales, Jaqueline Aschenbrenner

Creative Commons License
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.

Infarma - Ciências Farmacêuticas

ISSN - 2318-9312 (Versão eletrônica)

ISSN - 0104-0219 (Versão impressa)

Conselho Federal de Farmácia - CFF

SHIS QI 15 Lote "L" - Lago Sul - Brasília - DF

CEP: 71635-615 - Fone: (61)3878-8751

e-mail:infarma@cff.org.br

Diretoria

Walter da Silva Jorge João, Presidente do Conselho Federal de Farmácia

Lenira da Silva Costa, Vice-Presidente do Conselho Federal de Farmácia

João Samuel de Morais Meira, Tesoureiro do Conselho Federal de Farmácia

Luiz Gustavo de Freitas Pires, Secretário-Geral do Conselho Federal de Farmácia